Trials / Completed
CompletedNCT01916629
Photocil (Topical) for the Treatment of Psoriasis Vulgaris
Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Psoriasis Vulgaris
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Applied Biology, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of psoriasis
Detailed description
NB-UVB phototherapy is a common treatment for patients with psoriasis, and has been reported to be safe and effective in numerous clinical trials. Clinical trials have reported achievement of Psoriasis Area Severity Index (PASI)-75 in 50-70% of patients after 4-6 weeks of NB-UVB treatment. Many drawbacks limit patients compliance, access, and acceptance of traditional NB-UVB phototherapy. The strict treatment regimen (2-3 sessions per week for an average of 12 weeks or more) performed at a specialized phototherapy clinic combined with high cost and low or no reimbursement make compliance and access a major drawback. In order to address the drawbacks of phototherapy, we developed a novel topical cream - Photocil - that selectively delivers NB-UVB therapy when exposed to sunlight. When used with natural sunlight, Photocil provides a convenient alternative to traditional clinic based phototherapy; thus, has the potential to dramatically increase patient compliance and treatment outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Photocil for Psoriasis | Photocil for Psoriasis |
| OTHER | Placebo - Sunscreen (SPF 2) | Placebo - Sunscreen (SPF 2) |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-08-05
- Last updated
- 2016-03-10
- Results posted
- 2016-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01916629. Inclusion in this directory is not an endorsement.